A shadow economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Several professionals stated the popularity for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.
Platform Response and Content Elimination
According to TikTok, the platform has taken down violative material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Trading Operations
Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one community, a vendor posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Product Information and Costs
Within these communities, messages show dark colored packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
